These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma. You W, Ke J, Chen Y, Cai Z, Huang ZP, Hu P, Wu X. Front Immunol; 2022; 13():864244. PubMed ID: 35720314 [Abstract] [Full Text] [Related]
23. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma. Cao D, Wang Y, Li D, Wang L. Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009 [Abstract] [Full Text] [Related]
24. Exploring Unique Extracellular Vesicles Associated Signatures: Prognostic Insights, Immune Microenvironment Dynamics, and Therapeutic Responses in Pancreatic Adenocarcinoma. Nan K, Zhang M, Geng Z, Zhang Y, Liu L, Yang Z, Xu P. Mediators Inflamm; 2024; 2024():2825971. PubMed ID: 39220187 [Abstract] [Full Text] [Related]
25. ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway. Huang WK, Chen Y, Su H, Chen TY, Gao J, Liu Y, Yeh CN, Li S. Int J Biol Sci; 2021; 17(7):1808-1820. PubMed ID: 33994864 [Abstract] [Full Text] [Related]
27. Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis. Liu J, Nie S, Liang J, Jiang Y, Wan Y, Zhou S, Cheng W. J Cell Biochem; 2019 Sep; 120(9):15648-15660. PubMed ID: 31056798 [Abstract] [Full Text] [Related]
28. PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis. Kuang W, Wang X, Ding J, Li J, Ji M, Chen W, Wang L, Yang P. Front Immunol; 2022 Sep; 13():805311. PubMed ID: 35154122 [Abstract] [Full Text] [Related]
30. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. Zhou RS, Zhang EX, Sun QF, Ye ZJ, Liu JW, Zhou DH, Tang Y. BMC Cancer; 2019 Aug 07; 19(1):779. PubMed ID: 31391008 [Abstract] [Full Text] [Related]
31. Development of an autophagy-related signature in pancreatic adenocarcinoma. Yue P, Zhu C, Gao Y, Li Y, Wang Q, Zhang K, Gao S, Shi Y, Wu Y, Wang B, Xie J, Meng X. Biomed Pharmacother; 2020 Jun 07; 126():110080. PubMed ID: 32203889 [Abstract] [Full Text] [Related]
32. BCL2L1 is regulated by the lncRNA MIR4435-2HG-miR-513a-5p-BCL2L1 ceRNA axis and serves as a biomarker for pancreatic adenocarcinoma treatment and prognosis. Zhu R, Zhou H, Chen W, Bai S, Liu F, Wang X. Gene; 2024 Oct 20; 925():148615. PubMed ID: 38788819 [Abstract] [Full Text] [Related]
35. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN, Ma L, Liu N. J Transl Med; 2018 Sep 27; 16(1):264. PubMed ID: 30261893 [Abstract] [Full Text] [Related]
36. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma. Zhao R, Li FQ, Tian LL, Shang DS, Guo Y, Zhang JR, Liu M. Funct Integr Genomics; 2019 Jan 27; 19(1):109-121. PubMed ID: 30128795 [Abstract] [Full Text] [Related]